Literature DB >> 25995454

Casein Kinase 2 (CK2)-mediated Phosphorylation of Hsp90β as a Novel Mechanism of Rifampin-induced MDR1 Expression.

So Won Kim1, Md Hasanuzzaman2, Munju Cho2, Ye Rang Heo2, Min-Jung Ryu2, Na-Young Ha2, Hyun June Park3, Hyung-Yeon Park4, Jae-Gook Shin5.   

Abstract

The P-glycoprotein (P-gp) encoded by the MDR1 gene is a drug-exporting transporter located in the cellular membrane. P-gp induction is regarded as one of the main mechanisms underlying drug-induced resistance. Although there is great interest in the regulation of P-gp expression, little is known about its underlying regulatory mechanisms. In this study, we demonstrate that casein kinase 2 (CK2)-mediated phosphorylation of heat shock protein 90β (Hsp90β) and subsequent stabilization of PXR is a key mechanism in the regulation of MDR1 expression. Furthermore, we show that CK2 is directly activated by rifampin. Upon exposure to rifampin, CK2 catalyzes the phosphorylation of Hsp90β at the Ser-225/254 residues. Phosphorylated Hsp90β then interacts with PXR, causing a subsequent increase in its stability, leading to the induction of P-gp expression. In addition, inhibition of CK2 and Hsp90β enhances the down-regulation of PXR and P-gp expression. The results of this study may facilitate the development of new strategies to prevent multidrug resistance and provide a plausible mechanism for acquired drug resistance by CK2-mediated regulation of P-gp expression.
© 2015 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  ABC transporter; casein kinase 2 (CK2); colorectal cancer; drug resistance; heat shock protein 90 (Hsp90); heat shock protein 90 β (Hsp90β); permeability glycoprotein (P-gp); pregnane X receptor (PXR); rifampin; tuberculosis

Mesh:

Substances:

Year:  2015        PMID: 25995454      PMCID: PMC4505446          DOI: 10.1074/jbc.M114.624106

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  36 in total

Review 1.  One-thousand-and-one substrates of protein kinase CK2?

Authors:  Flavio Meggio; Lorenzo A Pinna
Journal:  FASEB J       Date:  2003-03       Impact factor: 5.191

Review 2.  Protein kinase CK2: a challenge to canons.

Authors:  Lorenzo A Pinna
Journal:  J Cell Sci       Date:  2002-10-15       Impact factor: 5.285

3.  The human nuclear xenobiotic receptor PXR: structural determinants of directed promiscuity.

Authors:  R E Watkins; G B Wisely; L B Moore; J L Collins; M H Lambert; S P Williams; T M Willson; S A Kliewer; M R Redinbo
Journal:  Science       Date:  2001-06-14       Impact factor: 47.728

4.  Nuclear receptor response elements mediate induction of intestinal MDR1 by rifampin.

Authors:  A Geick; M Eichelbaum; O Burk
Journal:  J Biol Chem       Date:  2001-01-31       Impact factor: 5.157

Review 5.  Mechanisms of cancer drug resistance.

Authors:  Michael M Gottesman
Journal:  Annu Rev Med       Date:  2002       Impact factor: 13.739

6.  Protein kinase CK2 in mammary gland tumorigenesis.

Authors:  E Landesman-Bollag; R Romieu-Mourez; D H Song; G E Sonenshein; R D Cardiff; D C Seldin
Journal:  Oncogene       Date:  2001-05-31       Impact factor: 9.867

7.  The replacement of ATP by the competitive inhibitor emodin induces conformational modifications in the catalytic site of protein kinase CK2.

Authors:  R Battistutta; S Sarno; E De Moliner; E Papinutto; G Zanotti; L A Pinna
Journal:  J Biol Chem       Date:  2000-09-22       Impact factor: 5.157

Review 8.  Transcriptional regulators of the human multidrug resistance 1 gene: recent views.

Authors:  Stéphane Labialle; Landry Gayet; Eric Marthinet; Dominique Rigal; Loris G Baggetto
Journal:  Biochem Pharmacol       Date:  2002-09       Impact factor: 5.858

Review 9.  Update on rifampin, rifabutin, and rifapentine drug interactions.

Authors:  Anne M Baciewicz; Cary R Chrisman; Christopher K Finch; Timothy H Self
Journal:  Curr Med Res Opin       Date:  2012-11-30       Impact factor: 2.580

Review 10.  Joining the cell survival squad: an emerging role for protein kinase CK2.

Authors:  Khalil Ahmed; Delphine A Gerber; Claude Cochet
Journal:  Trends Cell Biol       Date:  2002-05       Impact factor: 20.808

View more
  11 in total

Review 1.  Post-translational modifications of Hsp90 and translating the chaperone code.

Authors:  Sarah J Backe; Rebecca A Sager; Mark R Woodford; Alan M Makedon; Mehdi Mollapour
Journal:  J Biol Chem       Date:  2020-06-11       Impact factor: 5.157

2.  Role of c-Jun-N-Terminal Kinase in Pregnane X Receptor-Mediated Induction of Human Cytochrome P4503A4 In Vitro.

Authors:  Guncha Taneja; Chun Chu; Paramahamsa Maturu; Bhagavatula Moorthy; Romi Ghose
Journal:  Drug Metab Dispos       Date:  2018-02-12       Impact factor: 3.922

3.  Acetylation of lysine 109 modulates pregnane X receptor DNA binding and transcriptional activity.

Authors:  Danielle Pasquel; Aneta Doricakova; Hao Li; Sandhya Kortagere; Matthew D Krasowski; Arunima Biswas; William G Walton; Matthew R Redinbo; Zdenek Dvorak; Sridhar Mani
Journal:  Biochim Biophys Acta       Date:  2016-02-23

4.  New paradigms of USP53 disease: normal GGT cholestasis, BRIC, cholangiopathy, and responsiveness to rifampicin.

Authors:  Hamoud Alhebbi; Abdul Ali Peer-Zada; Abdulrahman A Al-Hussaini; Sara Algubaisi; Awad Albassami; Nasser AlMasri; Yasir Alrusayni; Ibrahim M Alruzug; Essa Alharby; Manar A Samman; Syed Zubair Ayoub; Sateesh Maddirevula; Roy W A Peake; Fowzan S Alkuraya; Sami Wali; Naif A M Almontashiri
Journal:  J Hum Genet       Date:  2020-08-06       Impact factor: 3.172

5.  Calorie Restriction Increases P-Glycoprotein and Decreases Intestinal Absorption of Digoxin in Mice.

Authors:  Helen J Renaud; Curtis D Klaassen; Iván L Csanaky
Journal:  Drug Metab Dispos       Date:  2016-01-07       Impact factor: 3.922

Review 6.  Regulation of PXR and CAR by protein-protein interaction and signaling crosstalk.

Authors:  Peter Oladimeji; Hongmei Cui; Chen Zhang; Taosheng Chen
Journal:  Expert Opin Drug Metab Toxicol       Date:  2016-06-23       Impact factor: 4.481

7.  Mechanisms of Resistance to Prostate-Specific Membrane Antigen-Targeted Radioligand Therapy in a Mouse Model of Prostate Cancer.

Authors:  Andreea D Stuparu; Joseph R Capri; Catherine A L Meyer; Thuc M Le; Susan L Evans-Axelsson; Kyle Current; Mark Lennox; Christine E Mona; Wolfgang P Fendler; Jeremie Calais; Matthias Eiber; Magnus Dahlbom; Johannes Czernin; Caius G Radu; Katharina Lückerath; Roger Slavik
Journal:  J Nucl Med       Date:  2020-12-04       Impact factor: 10.057

8.  BRCA1 mutations in high-grade serous ovarian cancer are associated with proteomic changes in DNA repair, splicing, transcription regulation and signaling.

Authors:  Eduard Sabidó; Anna Santamaria; Melissa Bradbury; Eva Borràs; Josep Castellví; Olga Méndez; José Luis Sánchez-Iglesias; Assumpció Pérez-Benavente; Antonio Gil-Moreno
Journal:  Sci Rep       Date:  2022-03-15       Impact factor: 4.379

9.  Human, vector and parasite Hsp90 proteins: A comparative bioinformatics analysis.

Authors:  Ngonidzashe Faya; David L Penkler; Özlem Tastan Bishop
Journal:  FEBS Open Bio       Date:  2015-11-14       Impact factor: 2.693

10.  Phosphorylation-Induced Ubiquitination and Degradation of PXR through CDK2-TRIM21 Axis.

Authors:  Mengyao Qin; Yu Xin; Yong Bian; Xuan Yang; Tao Xi; Jing Xiong
Journal:  Cells       Date:  2022-01-13       Impact factor: 6.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.